138 related articles for article (PubMed ID: 17416607)
21. Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia-reperfusion injury in rats.
Sun YM; Tian Y; Li X; Liu YY; Wang LF; Li J; Li ZQ; Pan W
Biochem Biophys Res Commun; 2009 May; 382(2):336-40. PubMed ID: 19275881
[TBL] [Abstract][Full Text] [Related]
22. Role of endothelial nitric oxide synthase and vagal activity in the endothelial protection of atorvastatin in ischemia/reperfusion injury.
Bi XY; He X; Zhao M; Yu XJ; Zang WJ
J Cardiovasc Pharmacol; 2013 May; 61(5):391-400. PubMed ID: 23364605
[TBL] [Abstract][Full Text] [Related]
23. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway.
Bell RM; Yellon DM
J Am Coll Cardiol; 2003 Feb; 41(3):508-15. PubMed ID: 12575984
[TBL] [Abstract][Full Text] [Related]
24. Effects of atorvastatin on sevoflurane postconditioning in in vivo rabbit hearts.
Kagawa K; Imaizumi U; Fuchida S; Sanuki T
J Oral Biosci; 2021 Sep; 63(3):253-258. PubMed ID: 34280533
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
[TBL] [Abstract][Full Text] [Related]
26. Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions.
Ye Y; Perez-Polo JR; Birnbaum Y
Ann N Y Acad Sci; 2010 Oct; 1207():76-82. PubMed ID: 20955429
[TBL] [Abstract][Full Text] [Related]
27. The protective effect of fasudil pretreatment combined with ischemia postconditioning on myocardial ischemia/reperfusion injury in rats.
Li WN; Wu N; Shu WQ; Guan YE; Jia DL
Eur Rev Med Pharmacol Sci; 2014; 18(18):2748-58. PubMed ID: 25317813
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
[TBL] [Abstract][Full Text] [Related]
29. Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta.
Lunder M; Ziberna L; Janić M; Jerin A; Skitek M; Sabovič M; Drevenšek G
Heart Vessels; 2013 Mar; 28(2):246-54. PubMed ID: 22610592
[TBL] [Abstract][Full Text] [Related]
30. Atorvastatin treatment improves the effects of mesenchymal stem cell transplantation on acute myocardial infarction: the role of the RhoA/ROCK/ERK pathway.
Zhang Q; Wang H; Yang YJ; Dong QT; Wang TJ; Qian HY; Li N; Wang XM; Jin C
Int J Cardiol; 2014 Oct; 176(3):670-9. PubMed ID: 25139321
[TBL] [Abstract][Full Text] [Related]
31. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
[TBL] [Abstract][Full Text] [Related]
32. Low-dose combination of alendronate and atorvastatin reduces ligature-induced alveolar bone loss in rats.
Goes P; Melo IM; Silva LM; Benevides NM; Alencar NM; Ribeiro RA; Lima V
J Periodontal Res; 2014 Feb; 49(1):45-54. PubMed ID: 23742139
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-21 Mediates Isoflurane-induced Cardioprotection against Ischemia-Reperfusion Injury via Akt/Nitric Oxide Synthase/Mitochondrial Permeability Transition Pore Pathway.
Qiao S; Olson JM; Paterson M; Yan Y; Zaja I; Liu Y; Riess ML; Kersten JR; Liang M; Warltier DC; Bosnjak ZJ; Ge ZD
Anesthesiology; 2015 Oct; 123(4):786-798. PubMed ID: 26259139
[TBL] [Abstract][Full Text] [Related]
34. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
35. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
36. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
[TBL] [Abstract][Full Text] [Related]
37. Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion.
Zhao XJ; Liu XL; He GX; Xu HP
Braz J Med Biol Res; 2014 Feb; 47(3):245-51. PubMed ID: 24554037
[TBL] [Abstract][Full Text] [Related]
38. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.
Gonon AT; Erbas D; Bröijersén A; Valen G; Pernow J
Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1767-74. PubMed ID: 14693683
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin protects against ischemia-reperfusion injury in fructose-induced insulin resistant rats.
Prakash P; Khanna V; Singh V; Jyoti A; Jain M; Keshari RS; Barthwal MK; Dikshit M
Cardiovasc Drugs Ther; 2011 Aug; 25(4):285-97. PubMed ID: 21671014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
